---
title: "DexCom Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293974864.md"
description: "DexCom Inc. (DXCM) shares rose 2.56% to $73.37, outperforming competitors Abbott Laboratories and Insulet Corp. on a strong trading day. This marks the second consecutive day of gains for DexCom, though it remains 18.46% below its 52-week high. The broader market also saw gains, with the S&P 500 up 0.02% and the Dow Jones Industrial Average up 0.51%. Trading volume was slightly below the 50-day average."
datetime: "2026-07-27T21:00:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293974864.md)
  - [en](https://longbridge.com/en/news/293974864.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293974864.md)
---

# DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DexCom Inc. (DXCM) rallied 2.56% to $73.37 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.

This was the stock's second consecutive day of gains.

DexCom Inc. closed 18.46% below its 52-week high of $89.98, which the company reached on July 30th.

The stock outperformed some of its competitors Monday, as Abbott Laboratories (ABT) rose 1.39% to $104.49 and Insulet Corp. (PODD) rose 1.07% to $165.00.

Trading volume (5.0 M) remained 676,974 below its 50-day average volume of 5.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-27-26 1700ET

### Related Stocks

- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)

## Related News & Research

- [Dexcom Q2 revenue beats estimates raises outlook; raises FY revenue and margin guidance](https://longbridge.com/en/news/294409327.md)
- [DexCom Earnings: What To Look For From DXCM](https://longbridge.com/en/news/294146285.md)
- [DXCM: Q2 2026 saw 13% revenue growth, record new patient starts, and raised guidance for revenue and margins](https://longbridge.com/en/news/294426207.md)
- [Dexcom raises annual revenue forecast on strong demand for glucose monitors](https://longbridge.com/en/news/294411617.md)
- [Dexcom Q2 FY26 GAAP net income rises 39% to $249.1 million; revenue climbs 13% to $1.31 billion](https://longbridge.com/en/news/294409311.md)